<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
placeholder

Considerations for Ordering Biomarker Testing in Endometrial Cancer

Bradley Corr, MD, discussed the importance of mismatch repair deficiency testing and the value of next-generation sequencing in patients with advanced endometrial cancer.

minute read

Written by Targeted Oncology on October 18, 2023

Related Stories